Nath Bio-Genes (India) Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 22, 2025. Further, the company has submitted the Exchange a copy of Srutinizers report along with copy of minutes.

Nath Bio-Genes (India) Limited held its 32nd Annual General Meeting on August 22, 2025, via video conferencing from 11:00 AM to 11:30 AM, with 63 shareholders attending (16 from promoter group and 47 from public). All seven resolutions were passed with overwhelming majority, including adoption of audited financial statements for FY ending March 31, 2025, and declaration of a final dividend of ₹2 per equity share (face value ₹10). The meeting also approved the re-appointment of Mrs. Jeevanlata Kagliwal as Director, the appointment of M/s Neha P Agrawal as Secretarial Auditor for five years (FY 2025-26 to FY 2029-30), and the appointment of Ms. Payal Jain as Independent Director along with re-appointments of Mr. Vadla Nagabhushanam and Mr. Madhukar Deshpande as Independent Directors for their second five-year terms. Voting results showed 99.99% approval on every resolution, with negligible votes against. The scrutinizer, Mrs. Neha P Agrawal (Practicing Company Secretary), supervised the e-voting process, which ran from August 19 to August 21, 2025.